Fortress Biotech Statistics Share Statistics Fortress Biotech has 29.57M
shares outstanding. The number of shares has increased by 10.39%
in one year.
Shares Outstanding 29.57M Shares Change (YoY) 10.39% Shares Change (QoQ) 7.12% Owned by Institutions (%) 18.57% Shares Floating 21.13M Failed to Deliver (FTD) Shares 26,264 FTD / Avg. Volume 12.84%
Short Selling Information The latest short interest is 3.13M, so 10.58% of the outstanding
shares have been sold short.
Short Interest 3.13M Short % of Shares Out 10.58% Short % of Float 13.41% Short Ratio (days to cover) 12.87
Valuation Ratios The PE ratio is -0.92 and the forward
PE ratio is -2.24.
Fortress Biotech's PEG ratio is
0.01.
PE Ratio -0.92 Forward PE -2.24 PS Ratio 0.73 Forward PS 0.5 PB Ratio 1.86 P/FCF Ratio -0.44 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Fortress Biotech.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.27,
with a Debt / Equity ratio of 3.34.
Current Ratio 1.27 Quick Ratio 1.06 Debt / Equity 3.34 Debt / EBITDA -0.73 Debt / FCF -0.8 Interest Coverage -11.12
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $571.04K Profits Per Employee $-455.42K Employee Count 101 Asset Turnover 0.4 Inventory Turnover 1.45
Taxes Income Tax 312K Effective Tax Rate -0.26%
Stock Price Statistics The stock price has increased by 8.47% in the
last 52 weeks. The beta is 1.76, so Fortress Biotech's
price volatility has been higher than the market average.
Beta 1.76 52-Week Price Change 8.47% 50-Day Moving Average 1.9 200-Day Moving Average 1.8 Relative Strength Index (RSI) 43.55 Average Volume (20 Days) 204,480
Income Statement In the last 12 months, Fortress Biotech had revenue of 57.67M
and earned -46M
in profits. Earnings per share was -2.69.
Revenue 57.67M Gross Profit 36.8M Operating Income -110.38M Net Income -46M EBITDA -104.49M EBIT -108.95M Earnings Per Share (EPS) -2.69
Full Income Statement Balance Sheet The company has 57.26M in cash and 75.96M in
debt, giving a net cash position of -18.7M.
Cash & Cash Equivalents 57.26M Total Debt 75.96M Net Cash -18.7M Retained Earnings -740.87M Total Assets 178.07M Working Capital 53.23M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -80.19M
and capital expenditures -15M, giving a free cash flow of -95.19M.
Operating Cash Flow -80.19M Capital Expenditures -15M Free Cash Flow -95.19M FCF Per Share -4.58
Full Cash Flow Statement Margins Gross margin is 63.8%, with operating and profit margins of -191.38% and -79.75%.
Gross Margin 63.8% Operating Margin -191.38% Pretax Margin -209% Profit Margin -79.75% EBITDA Margin -181.17% EBIT Margin -191.38% FCF Margin -165.05%
Dividends & Yields FBIO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for FBIO is $21,
which is 993.8% higher than the current price. The consensus rating is "Strong Buy".
Price Target $21 Price Target Difference 993.8% Analyst Consensus Strong Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 10, 2023. It was a
backward
split with a ratio of 1:15.
Last Split Date Oct 10, 2023 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -6.76 Piotroski F-Score 2
